by Clinical Neuropsychologist Online | Tuesday, July 23, 2024 | Dementia
Dementia, Volume 23, Issue 7, Page 1126-1151, October 2024. Background: This paper uses Normalization Process Theory (NPT) to examine staff impressions of Montessori-based program training and implementation at Veterans Affairs Community Living Centers (VA CLCs;...
by Clinical Neuropsychologist Online | Monday, July 22, 2024 | Dementia
Abstract A Nature Medicine paper published in January 2024 describes eight cases of iatrogenic Alzheimer’s disease in individuals who received cadaveric pituitary-derived human growth hormone. The paper’s conclusions argue for the transmissibility of...
by Clinical Neuropsychologist Online | Sunday, July 21, 2024 | Dementia
Dementia, Volume 23, Issue 7, Page 1152-1171, October 2024. Background and ObjectivesPrevious studies have found that falls among community-dwelling older people with dementia negatively impact the health and well-being of their relative/friend care partners. Limited...
by Clinical Neuropsychologist Online | Saturday, July 20, 2024 | Dementia
Abstract INTRODUCTION The immune receptor triggering receptor expressed on myeloid cells 2 (TREM2) is among the strongest genetic risk factors for Alzheimer’s disease (AD) and is a therapeutic target. TREM2 multimers have been identified in crystallography and...
by Clinical Neuropsychologist Online | Saturday, July 20, 2024 | Dementia
Abstract INTRODUCTION We examined whether baseline glial markers soluble triggering receptor expressed on myeloid cell 2 (sTREM2), chitinase 3-like protein 1 (YKL-40), and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF), and plasma GFAP are...
